Clinical Trial

A Clinical Study of AK139 in Healthy Subjects

Name: A Clinical Study of AK139 in Healthy Subjects — clinical trial record (NCT06947109)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Phase 1

View on ClinicalTrials.gov →

Record status

This record was last updated April 27, 2025 (before its estimated January 30, 2026 completion). Its status may not reflect the trial's current state.

Summary

This is a phase I clinical study on dose escalation evaluating the safety, tolerability, PK and PD of a single dose of AK139 administered subcutaneously in healthy subjects.

Trial Details

NCT Number	NCT06947109
Lead Sponsor	Akeso
Conditions	Healthy Subjects
Enrollment	48 participants
Start Date	2025-05-06
Primary Completion	2026-01-30 (estimated)
Study Completion	2026-01-30 (estimated)
Updated on ClinicalTrials.gov	2025-04-27